AstraZeneca Plc (NASDAQ: AZN)
$68.57
(-7.2%)
-$5.35
Price as of April 4, 2025, 3:58 p.m. ET
AZN
Key Data Points
Current Price
$68.57
Daily Change
(-7.2%) -$5.35
Day's Range
$68.44 - $72.03
Previous Close
$68.46
Open
$71.75
Beta
0.39
Volume
9,212,028
Average Volume
5,661,855
Sector
Market Cap
$212B
Market Cap / Employee
$2M
52wk Range
$62.75 - $87.68
Revenue
$54B
Gross Margin
72.23%
Dividend Yield
2.3%
EPS
$2.25
CAPs Rating
-
Industry
Pharmaceuticals
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
AstraZeneca Plc Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
AstraZeneca Plc Company Info
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
News & Analysis
The Fool has written over 400 articles on AstraZeneca Plc.
Featured Article
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
Prosper Junior Bakiny | Mar 21, 2025
Featured Article
3 Magnificent Growth Stocks to Buy Right Now
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Feb 22, 2025
What's a Good Price for AstraZeneca Stock?
Parkev Tatevosian, CFA | Feb 19, 2025
Why AstraZeneca Topped the Market on Thursday
Eric Volkman | Feb 6, 2025
3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices
David Jagielski | Jan 15, 2025
3 Cheap Growth Stocks to Buy in 2025
David Jagielski | Jan 9, 2025
Is AstraZeneca Stock a Buy?
Prosper Junior Bakiny | Dec 22, 2024
3 Unstoppable Stocks to Buy Right Now
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Dec 14, 2024
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Podcast Episodes

Talking About Vaccine News, Oil Predictions, and More
Discover why the stock price movement of AstraZeneca may be misleading.
Chris Hill | Dec 31, 2020
INDUSTRY FOCUS // Healthcare // 06-29-2016
Digesting how the U.K. decision to exit the EU could affect healthcare stocks here and abroad.
Todd Campbell and Kristine Harjes | Jul 3, 2016
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.